LORTAB Safety Questions, LORTAB Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LORTAB. Our extensive database of LORTAB adverse events and LORTAB warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LORTAB

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




LORTAB Safety Reports

Total LORTAB reports: 41.
LORTAB FDA safety alerts: No.
Reported deaths: 13    Reported hospitalizations: 17.
Take LORTAB Side Effects Survey or Share Your LORTAB Story. LORTAB Usage.

Physician from UNITED STATES reported LORTAB problem on Jan 19, 2007. Female patient, 53 years of age, weighting 285.6 lb, was diagnosed with pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, laboratory test abnormal, nuclear magnetic resonance imaging brain abnormal. LORTAB dosage: 10 MG PRN PO. During the same period patient was treated with KADIAN, MAXZIDE, SYNTHROID, DILANTIN, NEURONTIN. Patient was hospitalized. Patient recovered.

LORTAB problem was reported by a Health Professional from on Feb 08, 2007. Female patient, weighting 126.1 lb, was diagnosed with neurological symptom and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, hallucination, infection, oral intake reduced. LORTAB dosage: unknown. During the same period patient was treated with COUMADIN, OXALIPLATIN, LEUCOVORIN CALCIUM, LEXAPRO, FLUOROURACIL, ATIVAN, DETROL LA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Jan 26, 2007. Male patient, 32 years of age, was diagnosed with pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, adrenal haemorrhage, amnesia, anxiety, base excess negative, blood alcohol, blood bicarbonate decreased, blood calcium decreased, blood chloride increased. LORTAB dosage: unknown. During the same period patient was treated with LORCET, TALWIN NX, AMBIEN, NORCO, VICODIN, TEMAZEPAM, DALMANE, RESTORIL. Patient died on 09/21/2004.

LORTAB problem was reported by a Health Professional from on Feb 08, 2007. Female patient, weighting 126.1 lb, was diagnosed with neurological symptom and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: hallucination. LORTAB dosage: unknown. During the same period patient was treated with COUMADIN, OXALIPLATIN, LEUCOVORIN CALCIUM, LEXAPRO, FLUOROURACIL, ATIVAN, DETROL LA. Patient was hospitalized. Patient recovered.

Health Professional from reported LORTAB problem on Feb 08, 2007. Female patient, weighting 126.1 lb, was diagnosed with neurological symptom and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: hallucination. LORTAB dosage: unknown. During the same period patient was treated with COUMADIN, OXALIPLATIN, LEUCOVORIN CALCIUM, LEXAPRO, FLUOROURACIL, ATIVAN, DETROL LA. Patient was hospitalized. Patient recovered.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2007. Male patient, 32 years of age, was diagnosed with pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, adrenal haemorrhage, amnesia, anxiety, base excess decreased, blood bicarbonate decreased, blood calcium decreased, blood chloride increased, blood creatine increased. LORTAB dosage: unknown. During the same period patient was treated with LORCET, TALWIN NX, AMBIEN, NORCO, VICODIN, TEMAZEPAM, DALMANE, RESTORIL. Patient died on 09/21/2004.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Sept 25, 2006. Male patient, 66 years of age, was diagnosed with musculoskeletal chest pain, hypercholesterolaemia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abdominal distension, alcohol use, hepatic failure, hepatitis c positive, vomiting. LORTAB dosage: unknown. During the same period patient was treated with PERCOCET, ZOCOR, PRAVACHOL, ATENOLOL, ENALAPRIL MALEATE. Patient was hospitalized. Patient died on 03/01/2005.

LORTAB problem was reported by a Health Professional from UNITED STATES on Nov 22, 2006. Female patient, 56 years of age, was diagnosed with breakthrough pain, depression and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: blood ph increased, cardiac disorder, cardiac failure congestive, cardiomegaly, delirium, delusion, electrocardiogram st-t change, hallucination, lethargy. LORTAB dosage: unknown. During the same period patient was treated with FENTANYL CITRATE, FENTANYL CITRATE, OXYCONTIN, LEXAPRO, ACETAMINOPHEN, FLEXERIL, SEROQUEL, ALBUTEROL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Mar 12, 2007. Male patient was diagnosed with insomnia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: amnesia, impaired driving ability, sleep walking. LORTAB dosage: unknown. During the same period patient was treated with CELEXA, WELLBUTRIN, AMBIEN, IMITREX. Patient recovered.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2007. Male patient, 52 years of age, was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal tenderness, anaemia, convulsion, hepatosplenomegaly, histiocytosis haematophagic, hypothermia, subdural haematoma, tachycardia. LORTAB dosage: unknown. During the same period patient was treated with REGLAN, DIGOXIN, FLAGYL, LACTULOSE. Patient died.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Mar 12, 2007. Female patient was diagnosed with insomnia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, femur fracture, rib fracture, road traffic accident, skin laceration. LORTAB dosage: unknown. During the same period patient was treated with PROTONIX, ESTRADIOL, NEURONTIN, GLYBURIDE, ZOLOFT, AMBIEN. Patient recovered.

LORTAB problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Female patient, 56 years of age, was diagnosed with breakthrough pain, depression and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: angiopathy, cardiac failure congestive, delusion, electrocardiogram st-t change, hallucination, lethargy, paranoia. LORTAB dosage: unknown. During the same period patient was treated with FENTANYL CITRATE, FENTANYL CITRATE, OXYCONTIN, LEXAPRO, ACETAMINOPHEN, FLEXERIL, SEROQUEL, ALBUTEROL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Mar 31, 2006. Male patient was diagnosed with back pain, chest pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: constipation, insomnia, mood altered, psychotic disorder, somnolence. LORTAB dosage: unknown. During the same period patient was treated with METHADONE. Patient recovered.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2006. Female patient, 47 years of age, weighting 173.1 lb, was diagnosed with back pain, intestinal functional disorder and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, overdose. LORTAB dosage: 10 MG 6/D PO. During the same period patient was treated with METHADONE HYDROCHLORIDE, OXYCODONE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LORTAB problem on May 10, 2005. Female patient, 53 years of age, was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: emotional disorder, gastric ulcer, gastritis, haematochezia, hypertension, hypoacusis, injury, intestinal obstruction. LORTAB dosage: unknown. During the same period patient was treated with TUSSIONEX, NEXIUM, WELLBUTRIN, VIOXX, FOSAMAX, CLARITIN, MERIDIA. Patient recovered.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Male patient was diagnosed with insomnia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: amnesia, impaired driving ability, sleep walking. LORTAB dosage: unknown. During the same period patient was treated with CELEXA, WELLBUTRIN, AMBIEN, IMITREX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Apr 19, 2007. Female patient, 36 years of age, weighting 264.6 lb, was diagnosed with breakthrough pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, constipation, gastrointestinal motility disorder. LORTAB dosage: unknown. During the same period patient was treated with FENTANYL, MORPHINE, DURAGESIC, ZOLPIDEM TARTRATE, TIAGABINE, LEVOTHYROXINE, MONTELUKAST, TRIAMCINOLONE ACETONIDE. Patient was hospitalized. Patient recovered.

LORTAB problem was reported by a Health Professional from UNITED STATES on May 10, 2007. Female patient, weighting 277.0 lb, was diagnosed with neuropathy peripheral, pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: nausea, pruritus. LORTAB dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported LORTAB problem on May 07, 2007. Female patient was diagnosed with insomnia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, femur fracture, overdose, rib fracture, road traffic accident, skin laceration. LORTAB dosage: unknown. During the same period patient was treated with PROTONIX, ESTRADIOL, NEURONTIN, GLYBURIDE, ZOLOFT, AMBIEN. Patient was hospitalized. Patient recovered.

LORTAB problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, 39 years of age, weighting 264.6 lb, was diagnosed with pain management, intestinal functional disorder and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: biliary dilatation, food poisoning, hepatitis. LORTAB dosage: 30 MG 4/D PO. During the same period patient was treated with ALVIMOPAN, ACETAMINOPHEN, SETRALINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LORTAB problem on May 24, 2006. Female patient, 14 years of age, was diagnosed with pain, sickle cell anaemia, asthma and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chest pain, cytomegalovirus antibody positive, gamma-glutamyltransferase increased, hepatitis. LORTAB dosage: unknown. During the same period patient was treated with EXJADE, ADVAIR DISKUS, SINGULAIR, ALBUTEROL SPIROS, FOLIC ACID. Patient was hospitalized. Patient recovered.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2006. Male patient, 66 years of age, was diagnosed with musculoskeletal chest pain, hypercholesterolaemia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: alcohol problem, blood alcohol increased, blood alkaline phosphatase increased, blood bilirubin increased, hepatic failure, impaired driving ability, rib fracture, road traffic accident. LORTAB dosage: unknown. During the same period patient was treated with PERCOCET, ZOCOR, ALCOHOL, ANTIHYPERTENSIVE. Patient died on 06/28/2006.

Physician from UNITED STATES reported LORTAB problem on Aug 16, 2006. Female patient, weighting 126.0 lb, was diagnosed with rheumatoid arthritis and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. LORTAB dosage: unknown. Patient recovered.

LORTAB problem was reported by a Physician from UNITED STATES on Aug 16, 2006. Female patient, weighting 110.0 lb, was diagnosed with back pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alopecia, nausea. LORTAB dosage: 5MG BID PO. During the same period patient was treated with DARVOCET. Patient recovered.

Physician from UNITED STATES reported LORTAB problem on Aug 22, 2006. Female patient, weighting 126.0 lb, was diagnosed with rheumatoid arthritis and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. LORTAB dosage: unknown. Patient recovered.

LORTAB problem was reported by a Physician from UNITED STATES on Aug 21, 2006. Female patient, weighting 110.0 lb, was diagnosed with back pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alopecia, nausea. LORTAB dosage: 5 MG BID PO. During the same period patient was treated with DARVOCET. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Sept 14, 2006. Male patient, 66 years of age, was diagnosed with musculoskeletal chest pain, hypercholesterolaemia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abdominal distension, hepatic failure, hepatitis c, pleural effusion, rib fracture, umbilical hernia, vomiting. LORTAB dosage: unknown. During the same period patient was treated with PERCOCET, ZOCOR, ALCOHOL, PRAVACHOL, ANTIHYPERTENSIVE, ATENOLOL, ENALAPRIL MALEATE. Patient died on 03/01/2005.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: accidental overdose, vomiting. LORTAB dosage: unknown. During the same period patient was treated with ULTRAM, REBIF, LUNESTA, DEPAKOTE. Patient died on 07/26/2006.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Sept 25, 2006. Male patient, 66 years of age, was diagnosed with musculoskeletal chest pain, hypercholesterolaemia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: abdominal distension, alcohol use, hepatic failure, hepatitis c positive, vomiting. LORTAB dosage: unknown. During the same period patient was treated with PERCOCET, ZOCOR, PRAVACHOL, ATENOLOL, ENALAPRIL MALEATE. Patient was hospitalized. Patient died on 03/01/2005.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: vomiting. LORTAB dosage: unknown. During the same period patient was treated with REBIF, ULTRAM, LUNESTA, DEPAKOTE. Patient died on 07/26/2006.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Oct 27, 2006. Male patient, 66 years of age, was diagnosed with musculoskeletal chest pain, hypercholesterolaemia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: alcoholism, hepatic failure, hepatitis c positive. LORTAB dosage: unknown. During the same period patient was treated with PERCOCET, ZOCOR, ALCOHOL, PRAVACHOL, ANTIHYPERTENSIVE, ATENOLOL, ENALAPRIL MALEATE. Patient died on 03/01/2005.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 22, 2006. Female patient, 56 years of age, was diagnosed with breakthrough pain, depression and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: blood ph increased, cardiac disorder, cardiac failure congestive, cardiomegaly, delirium, delusion, electrocardiogram st-t change, hallucination, lethargy. LORTAB dosage: unknown. During the same period patient was treated with OXYCONTIN, LEXAPRO, TYLENOL, FLEXERIL, SEROQUEL, ALBUTEROL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Dec 08, 2006. Male patient, 37 years of age, was diagnosed with breakthrough pain, back pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: completed suicide, constipation, depression, emotional distress, intentional overdose, loss of consciousness, musculoskeletal stiffness. LORTAB dosage: 10 MG /D PO. During the same period patient was treated with KADIAN, VALIUM, LIBRIUM, TYLENOL, ZYRTEC. Patient died on 11/09/2004.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Female patient, 35 years of age, was diagnosed with back pain, neck pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. LORTAB dosage: unknown. During the same period patient was treated with SKELAXIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Aug 08, 2007. Female patient was diagnosed with cancer pain, depression, lung neoplasm malignant and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: confusional state, dyspnoea. LORTAB dosage: 5 MG, QD. During the same period patient was treated with LEXAPRO, SPIRIVA, SEREVENT. Patient recovered.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2007. Female patient, 38 years of age, was diagnosed with postoperative analgesia and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: hepatic encephalopathy, hepatic necrosis, overdose, renal failure. LORTAB dosage: 7.5 MG PO. During the same period patient was treated with PROPOXYPHENE NAPSYLATE. Patient died.

Physician from UNITED STATES reported LORTAB problem on Aug 24, 2007. Female patient, weighting 153.0 lb, was diagnosed with anxiety, muscle spasms and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: anxiety, diarrhoea, headache, muscle spasms, nausea, pain, stomach discomfort. LORTAB dosage: unknown. During the same period patient was treated with VALIUM. Patient recovered.

LORTAB problem was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Female patient was diagnosed with musculoskeletal pain, epilepsy, urinary tract infection and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: white blood cell count decreased. LORTAB dosage: unknown. During the same period patient was treated with RUFINAMIDE, BACTRIM, LEVAQUIN, LEVETIRACETAM, LAMOTRIGINE, BACTROBAN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LORTAB problem on Aug 22, 2007. Female patient, 67 years of age, was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: condition aggravated, diarrhoea, diverticulitis, fall, intervertebral disc disorder, nausea, spinal compression fracture, vomiting. LORTAB dosage: unknown. During the same period patient was treated with KLONOPIN, PARACETAMOL, PROZAC, SYNTHROID, ATENOLOL, SINGULAIR, RHINOCORT, NEXIUM. Patient was hospitalized. Patient recovered.

LORTAB problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, 72 years of age, was diagnosed with back pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: rash. LORTAB dosage: unknown. During the same period patient was treated with SKELAXIN, SYNTHROID, LISINOPRIL, ZOCOR, PLAVIX, PREVACID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LORTAB problem on Sept 22, 2006. Female patient, 54 years of age, was diagnosed with multiple sclerosis, pain and was treated with LORTAB. After drug was administered, patient experienced the following problems/side effects: accidental overdose, vomiting. LORTAB dosage: unknown. During the same period patient was treated with REBIF, ULTRAM, LUNESTA, DEPAKOTE. Patient died on 07/26/2006.

Ask Our Patient Community about LORTAB

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert
RituximabThis drug has as active FDA Safety Alert
Rivastigmine tartrate
RizatriptanThis drug has as active FDA Safety Alert
RocephinThis drug has as active FDA Safety Alert (ceftriaxone)
Rofecoxib
RosuvastatinThis drug has as active FDA Safety Alert
Rozerem (ramelteon)

back to top

S
Sacrosidase
Salmeterol xinafoate

Sanctura (trospium)
Seconal (secobarbital)
Secobarbital
Selzentry
Sensipar (cinacalcet)
Serevent Diskus (salmeterol xinafoate)
Seroquel (quetiapine)
Sertaconazole
SertralineThis drug has as active FDA Safety Alert
SerzoneThis drug has as active FDA Safety Alert (nefazodone)
Sevelamer
Sildenafil citrate